Applying For Approvals

The University of ÐÂÀ˲ÊƱ Institutional Biosafety Committee review applications for gene technology and microbiological activities.

Applications for gene technology teaching or research, and microbiological research are accepted from:

  • University of ÐÂÀ˲ÊƱ staff or students.
  • Personnel from other institutions who are working in University of ÐÂÀ˲ÊƱ premises,
  • Personnel from other institutions, organisations or companies who have agreements to access The University of ÐÂÀ˲ÊƱ IBC for their GMO approvals.

The following types of applications are required prior to commencement of a project. Work cannot commence until an approval or endorsement of the application is received. The Gene Technology and Microbiological Risk Assessment applications will need to be submitted via the ÐÂÀ˲ÊƱ Compliance and Ethics System (ACES).

Ìý

Note: Confidentiality of Commerical Information

If anything in the GMO Dealing Application is confidential commercial information, do not enter information into the below form. Contact ibc@adelaide.edu.au before preparing the application.Ìý

Ìý

Ìý'how-to' guides

  • Gene technology applications

    For teaching or research that falls under the following categories of dealings defined within the Gene Technology Act:

    • Exempt dealings.
    • Notifiable Low Risk dealings.
    • Dealings Not Involving Intentional Release (DNIR) licences.
    • Dealings Involving Intentional Release (DIR) licences.

    Applications for exempt and NLRD dealings are submitted via the ÐÂÀ˲ÊƱ Compliance and Ethics System (ACES) using the Biological Compliance - GMO Dealing Application form.

    For DNIR and DIR licences, the University of ÐÂÀ˲ÊƱ must submit the licence application to the Office of the Gene Technology Regulator (OGTR). Please contact the Research Compliance Officer to discuss the application process.

  • Microbiological risk assessment applications

    For research with non-genetically modified microorganisms meeting any of the following criteria:

    • Storage of, or work with, risk group 2 microorganisms including bacteria, viruses, parasites, fungi, algae or prions that may cause disease in, or are pathogenic, allergenic or toxic to humans, animals, plants or aquatic organisms.
    • Isolation or culture of microorganisms from human or animal bodily fluids or tissues.
    • Handling plants or animals that are knowingly infected with a microorganism capable of causing disease – i.e., infected as part of the research, or obtained for the purpose of investigating a specific disease agent known to be present.
    • Storage of, or work with, primary cells or cell lines that are known or reasonably suspected to contain risk group 2 microorganisms (excluding Mycoplasma contaminants).
    • Isolation, culture or enrichment of unknown microorganisms from environmental samples where the methods used are designed or intended for isolation, cul